INHIBIKASE THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • April 19th, 2024 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledApril 19th, 2024 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of April 1, 2024 (the “Effective Date”), by and between INHIBIKASE THERAPEUTICS, INC. (the “Company”), and Garth Lees-Rolfe (the “Employee”).
INHIBIKASE THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • April 2nd, 2024 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledApril 2nd, 2024 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of April 1, 2024 (the “Effective Date”), by and between INHIBIKASE THERAPEUTICS, INC. (the “Company”), and Garth Lees-Rolfe (the “Employee”).
INHIBIKASE THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 23rd, 2020 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 23rd, 2020 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (hereinafter referred to as this “Agreement”) is dated October 24, 2018, with the intent that it be effective as of and from the Effective Date (defined below), by and between INHIBIKASE THERAPEUTICS (the “Company”), and Joseph Frattaroli (the “Employee”).